Modern Slavery Act Statement 2020 (the "Act")

Introduction

Life UK Healthcare Limited (“LUHL”) is part of the Life Healthcare Group and is the UK holding company for a group of companies that operates in a number of countries including the UK. LUHL does not trade itself, the business in the UK is operated through its subsidiary companies Alliance Medical Limited (“AML”), Alliance Medical Radiopharmacy Limited (“AMRL”), Alliance Medical Leasing Limited (“AMLL”), Alliance Diagnostic Services Limited (“ADSL”) and the European Scanning Centre (Harley Street) Limited (“ESC”) (“AML, AMRL, AMLL, ADSL and ESC” together being referred to as the UK Entities).

UK Business Overview

AML is a provider of complex diagnostic imaging services, and has provided those services for more than 30 years either through itself or its other trading subsidiary ADSL. ESC is also a provider of complex diagnostic imaging services which utilises innovative and advanced scanning equipment. AMRL manufactures and distributes radiopharmaceutical products which are used in conjunction with the diagnostic imaging services. AMLL purchases scanning equipment that is used by AML at certain sites to provide its diagnostic imaging services and is the principal contracting party for construction and development contracts for certain new sites. The UK Entities work collaboratively with clinicians, public and private healthcare organisations and academic institutions to provide high quality and cost effective diagnostic imaging services and radiopharmaceuticals to its customers and for its patients.

The UK Entities’ supply chain includes procurement of scanning equipment and associated information technology equipment, transportation of mobile  scanning units and radiopharmaceuticals, agency staff, medical and nonmedical consumables, and construction and maintenance of buildings.

Commitment

The UK Entities are committed to combating the real and growing problem of modern slavery and human trafficking.

We recognise that it can affect any sector or industry and we take seriously our responsibility to be alert to the risks, however small, in our business and in our wider supply chain.

We expect our people and our suppliers to share our commitment to ensuring modern slavery and human trafficking do not exist in our business or supply chains.

Our Policies

The Life Healthcare Group have developed a Global Code of Conduct that incorporates references to combatting modern slavery and human trafficking which the UK Entities are committed to complying with.

We operate employment policies and procedures that are designed to treat all individuals who work within our business with dignity and respect, to reward them fairly for their work and not to exploit them.

We only wish to work with organisations in our supply chains that have a similar commitment and are not involved in modern slavery, or human trafficking.

While it is the obligation of those organisations to operate their own policies and procedures to achieve that objective, we will develop and build upon our existing practices to ensure we take all reasonable steps to verify compliance by all material direct suppliers with the Act.

Assessment of Risk within our Supply Chain

We have carried out a high level assessment of our supply chains and the potential for slavery and human trafficking. As the vast majority of our suppliers are based in the UK and many are operating in specialised rather than low skilled industries, our supply chains have been assessed overall as posing a low risk in terms of non-compliance with the Act. However, we will continue to periodically review and re-assess this risk and are committed to procuring goods and services in a manner which recognises the importance of human rights, and we expect all of our suppliers to honour and observe the same principles.

Actions to be undertaken in the next 12 months

  • To develop a due diligence process in respect of our material direct suppliers.
  • To develop a specific anti-slavery policy to evidence our commitment to the principles of the Act.
  • To obtain assurance from material direct suppliers in relation to their continued compliance with the Act.
  • To ensure contractual clauses are included in our supplier contracts requiring suppliers to provide undertakings to comply with the provisions of the Act.
  • To ensure that these contractual clauses are included in future supply contracts and contract renewals.
  • To continually review the provisions of the Act in relation to all business activities.

Approval by the Board of Directors

Each of the board of directors of the UK Entities has approved this statement for the financial year ending 30 September 2019

Pieter Van Der Westhuizen – Group Chief Financial Officer

March 2020